MSLE – satellos bioscience inc. (US:NASDAQ)
Stock Stats
News
Satellos Bioscience (MSLE) was downgraded by Wall Street Zen to "stro
Satellos Bioscience (MSLE) is now covered by Cantor Fitzgerald. They set an "overweight" rating on the stock.
Satellos Presents Interim SAT-3247 Clinical and Biomarker Data in Duchenne Muscular Dystrophy at the 2026 MDA Clinical & Scientific Conference [Yahoo! Finance]
Satellos Presents Interim SAT-3247 Clinical and Biomarker Data in Duchenne Muscular Dystrophy at the 2026 MDA Clinical & Scientific Conference
Satellos Announces Upcoming Oral and Poster Presentations at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference
Form 6-K Satellos Bioscience Inc. For: Mar 10
Form 6-K Satellos Bioscience Inc. For: Feb 24
Form 6-K Satellos Bioscience Inc. For: Feb 19
Form 6-K Satellos Bioscience Inc. For: Feb 18
Form 6-K Satellos Bioscience Inc. For: Feb 17
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.